Boltz-2’s development was led by the Boltz team at MIT under the supervision of Professors Regina Barzilay and Tommi Jaakkola alongside a team of researchers from MIT and Recursion. For more ...

Apple debunks the hype around A.I. with a study showing that models struggle with complex reasoning, despite advanced ...

Let's call it the Permutation Curve. Simply put, this curve is the exponential explosion of new possibilities from the ...

Key Takeaways Prep smarter with real-world coding challenges, system design scenarios, and behavioral questions tailored for ...

The MIT model predicts molecular binding affinity at newfound speed and accuracy, offering a powerful tool for commercial drug discovery.

Investor capital is pouring into AI-driven healthcare, with Pittsburgh-based Abridge AI Inc. pulling in $300 million at a ...

Abstract: Two recursive algorithms for computing the weight distributions of certain binary irreducible cyclic codes of length n in the so-called index 2 case are presented. The running times of these ...

Heart disease is the leading cause of death in the United States, taking a life every 33 seconds and accounting for about 20% ...

Recursion Pharmaceuticals (RXRX) stock gains as the company plans a 20% workforce reduction to streamline operations and ...

Recursion is eliminating approximately 20% of its workforce, in a restructuring that reflects challenges seen across the biopharma industry.

Recursion Pharmaceuticals said on Tuesday it will lay off around 20% of its workforce and focus on developing drugs for rare diseases and cancers to reduce cash burn during a prolonged biotech ...